Fertilizer Crisis: Supply Chain Collapse Threatens Bayer, Nestlé, MustGrow, and K+S! Where are the Opportunities for Investors?

Bayer and Nestlé – Facing the Impact of Global Shortages

The global trade distortions caused by the Middle East crisis have not yet reached supermarket shelves. However, upstream production stages in the food sector are currently grappling with significant cost increases, including fossil fuels up 40%, organic raw materials up 25%, and critical metals for production processes up 20%. It is only a matter of time before consumers have to bear these noticeable price hikes.

The diversified conglomerates Bayer and Nestlé are primarily feeling the impact of higher energy, raw material, and transportation costs, which are affecting their operating cost base. This is particularly relevant for Bayer, as energy-intensive processes in agricultural chemicals are sensitive to price fluctuations in gas and feedstocks. In the agricultural sector, a prolonged rise in energy and raw material costs can put margins under significant pressure, especially since energy often accounts for 30 to 40% of production costs. Strategically, the risk therefore lies less in immediate supply disruptions than in rising manufacturing costs and higher working capital. At Nestlé, the impact is most evident in logistics: rerouting of freight routes can extend transit times between Europe and Asia by 10 to 15 days, thereby dramatically increasing freight rates and storage costs. Supply disruptions would likely occur if disruptions persist for months!

For investors, the current situation thus primarily means increased earnings and price volatility, but not a structural supply weakness. Both companies have multi-sourcing and scalable supply chains, which enable pricing power, thereby strengthening their resilience to regional disruptions. The decisive factors remain how long the geopolitical uncertainty persists and to what extent cost increases can be passed on to customers. Analysts on the LSEG Refinitiv platform have not yet priced in the current external factors. Accordingly, the weighted 12-month price target for Bayer stands at EUR 44.84 (+14%), while Nestlé’s is at EUR 85.67 (+9.5%). As a precaution in light of potential further global bottlenecks, both stocks currently appear more like sell positions.

MustGrow – A Game-Changer in the Field of Biological Fertilizer Alternatives

In the right place at the right time. At a time when potash fertilizer is trading like gold, some farmers are having to switch to cheaper alternatives. The Canadian agricultural biotech firm MustGrow Biologics Corp. is positioning itself precisely in this market, which is structurally shifting toward sustainable and organic solutions. This is driven by a global trend: increasing regulatory requirements, a growing need for healthy soils, and an agricultural sector that must simultaneously deliver higher yields and meet environmental standards. At the same time, major agricultural corporations are increasingly investing in biological technologies, as these are achieving growth rates of around 10 to 20% per year and are thus expanding significantly faster than traditional chemical pesticides. Experts estimate that the global market for biological crop protection solutions could reach a volume of around USD 15 to USD 16 billion by the end of the decade, providing fertile ground for MustGrow’s rapid growth.

The innovative Canadian company has launched a technology platform based on natural plant compounds that can be used both to combat soil pests and to improve soil quality. The underlying concept leverages the natural defense mechanisms of certain plants and translates them into agricultural applications with repeatable use. This has resulted in several products, including solutions to promote root growth and strengthen crops’ resilience to stress factors. Of particular interest is the potential for recurring revenue in specialty crops such as fruits, vegetables, or seed production, where high margins and stable demand are typical. Organic agricultural producers today rely on a range of ESG certifications; MustGrow provides corresponding solutions.

Operationally, the company is in a phase of transition from research and development toward broader commercialization of its products. Initial sales have already been achieved in North America, with demand at times exceeding available production capacity, indicating early market access and growing interest. At the same time, management is pursuing a dual business model consisting of direct sales and licensing partnerships with established agricultural corporations, which allows for the partial outsourcing of development and regulatory approval costs. An international collaboration with a major industry player enables the company to tap into new markets and streamline regulatory processes. Technologically, MustGrow possesses an extensive patent portfolio of more than 110 intellectual property rights, which serve as a barrier to entry for competitors and can support the long-term monetization of the platform.

Particularly revealing are recent field trials involving a major North American crop, in which soil pathogens were reduced by up to 95%. Such results increase the likelihood that biological solutions will be used in the future not only as a supplement but increasingly as an integral part of modern farming systems. Financially, the company remains relatively lean, which is typical for growth-oriented small-cap companies. Following a capital raise of approximately CAD 2 million and a share count of about 63 million shares, the market valuation stands at approximately CAD 40 million. In the current environment, the company is likely to continue its recent surge unabated, as investors recognize its relevance in both the short and long term.

COO Colin Bletsky explained how the technology works at the 18th International Investment Forum.

https://youtu.be/XFGCBf1w8mg

K+S – Not Yet on the Buy List Despite Higher Earnings Estimates

The German fertilizer giant K+S is the absolute beneficiary of the current supply crunch. Some may view this as unethical; others say that is just how business works. K+S, a company over 130 years old (founded in 1889), is one of the world’s leading suppliers of potash and magnesium-containing products. Now is harvest time, as the company has every reason to raise its prices. The stock market seems to agree. The onset of the Iran crisis technically fits into a strong upward trend that began back in January at around EUR 12. The price briefly surpassed EUR 18, but the subsequent technical consolidation following a 50% rise has brought it back down to around EUR 15.20 over the past two weeks.

The latest analyst ratings from UBS and Deutsche Bank were disappointing. Although the experts have slightly raised their EBITDA forecasts, global risks for the fertilizer business are likely to remain dominant through 2026. As a result, both firms maintain a “Sell” rating with price targets of EUR 11.50 and EUR 10.20, respectively. At least 8 out of 23 analysts on the LSEG Refinitiv platform have managed to issue a “Buy” recommendation. This results in a weighted 12-month consensus of EUR 14.58. Some firms will likely revisit their calculations and, due to potential price increases, also expect better profits for K+S. In our view, the temporary high of EUR 18 should therefore be quickly surpassed on the second attempt.

The global state of the markets is cause for concern. While large technology companies are most affected by supply chain disruptions, it is also becoming clear that food supply is by no means immune to such pressures. If there is a global shortage of potash fertilizer, crop yields could plummet in 2026. This should give the shares of K+S and MustGrow a new boost, as suitable solutions are already available.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.